Cargando…

COVID-19, the Future Vaccine and What It Means for Cancer Patients on Immunotherapy

Detalles Bibliográficos
Autores principales:	El-Shakankery, Karim Hussien, Kefas, Joanna, Miller, Rowan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882718/ https://www.ncbi.nlm.nih.gov/pubmed/33598436 http://dx.doi.org/10.3389/fonc.2020.631611

Ejemplares similares

Caring for our cancer patients in the wake of COVID-19
por: El-Shakankery, Karim Hussien, et al.
Publicado: (2020)

Targeting HPV in gynaecological cancers – Current status, ongoing challenges and future directions
por: Crusz, Shanthini M, et al.
Publicado: (2020)

PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies
por: Miller, Rowan E, et al.
Publicado: (2022)

Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors
por: Miller, Rowan E, et al.
Publicado: (2022)

Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma?
por: Gao, Xiaoni, et al.
Publicado: (2023)

Past, Current, and Future of Immunotherapies for Prostate Cancer
por: Boettcher, Adeline N., et al.
Publicado: (2019)

COVID Vaccination in Cancer Patients: What Vaccination Priority Strategies Should There Be?
por: Silvestris, Nicola, et al.
Publicado: (2021)

Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?
por: Tanda, Enrica Teresa, et al.
Publicado: (2021)

What does endemic COVID-19 mean for the future of rituximab?
por: Liew, David F L, et al.
Publicado: (2022)

Treatment of Retinoblastoma: What Is the Latest and What Is the Future
por: Schaiquevich, Paula, et al.
Publicado: (2022)

Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
por: He, Yuqing, et al.
Publicado: (2021)

Immunotherapy in non-small cell lung cancer: Past, present, and future directions
por: Punekar, Salman R., et al.
Publicado: (2022)

HIGHLIGHTING THE RISE OF VACCINE-ASSOCIATED MYOCARDITIS AND WHAT IT MEANS FOR THE FUTURE OF MRNA VACCINES
por: Anthony, Jamal A., et al.
Publicado: (2022)

Immunotherapies of retinoblastoma: Effective methods for preserving vision in the future
por: Wang, Ling, et al.
Publicado: (2022)

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
por: Li, Ying, et al.
Publicado: (2023)

Immunotherapy for extensive-stage small-cell lung cancer: current landscape and future perspectives
por: Zhang, Shuang, et al.
Publicado: (2023)

The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives
por: Gandini, Annalice, et al.
Publicado: (2023)

Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)

What does 95% COVID-19 vaccine efficacy really mean?
por: Olliaro, Piero
Publicado: (2021)

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy
por: Zhang, Yuguo, et al.
Publicado: (2022)

Concerns with the use of Genelyn cadavers for surgical simulation
por: Chouari, Tarak Agrebi Moumni, et al.
Publicado: (2016)

Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?
por: Bai, Rilan, et al.
Publicado: (2020)

Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China
por: Xiong, Anwen, et al.
Publicado: (2021)

What reinfections mean for COVID-19
por: Iwasaki, Akiko
Publicado: (2021)

The Role of MRI Pancreatic Protocol in Assessing Response to Neoadjuvant Therapy for Patients With Borderline Resectable Pancreatic Cancer
por: Hussien, Nervana, et al.
Publicado: (2022)

COVID-19 vaccination in patients with cancer: Opportunities and challenges
por: Al-qaim, Zahraa Haleem, et al.
Publicado: (2022)

Meaning and Significance of “Alkalization Therapy for Cancer”
por: Wada, Hiromi, et al.
Publicado: (2022)

Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy
por: Prunaretty, Jessica, et al.
Publicado: (2023)

Cancer patients and COVID-19 vaccination, from safety to protocol adherence: A real-life setting report
por: Lamtai, Haitam, et al.
Publicado: (2022)

Immunotherapy Targets in Pediatric Cancer
por: Orentas, Rimas J., et al.
Publicado: (2012)

Mechanisms of Cancer Resistance to Immunotherapy
por: Bai, Rilan, et al.
Publicado: (2020)

Curcumin as an Adjuvant to Cancer Immunotherapy
por: Paul, Silpita, et al.
Publicado: (2021)

The Role of Neoantigens in Cancer Immunotherapy
por: Zhu, Yueting, et al.
Publicado: (2021)

Editorial: Personalized immunotherapy for cancer
por: Pasetto, Anna, et al.
Publicado: (2023)

Projected Impact of Weight Gain During the COVID-19 Pandemic on the Future Burden of Cancer in Canada
por: Murphy, Rachel A., et al.
Publicado: (2022)

What is the future of treatment de-escalation for HPV-positive oropharyngeal cancer? A review of ongoing clinical trials
por: Mensour, Emma A., et al.
Publicado: (2022)

Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review
por: Guven, Deniz C., et al.
Publicado: (2021)

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic
por: Kiss, Zoltán, et al.
Publicado: (2023)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

Ramadan Fasting and Patients with Cancer: State-of-the-Art and Future Prospects
por: Bragazzi, Nicola Luigi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pk43jh4umn5mbngpl1a9laojro